Drive Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$180K Sell
12,416
-3,396
-21% -$45.8K 0.03% 434
2026
Q1
$219K Buy
15,812
+115
+0.7% +$1.6K 0.05% 332
2025
Q4
$220K Buy
15,697
+2,555
+19% +$35.8K 0.04% 339
2025
Q3
$184K Sell
13,142
-40
-0.3% -$576 0.04% 344
2025
Q2
$198K Buy
13,182
+2,198
+20% +$31.4K 0.04% 324
2025
Q1
$145K Sell
10,984
-2,467
-18% -$34K 0.03% 308
2024
Q4
$212K Sell
13,451
-234
-2% -$3.52K 0.05% 298
2024
Q3
$217K Buy
13,685
+180
+1% +$2.9K 0.06% 275
2024
Q2
$206K Buy
+13,505
New +$194K 0.06% 281

Other funds holding RDY

Drive Wealth Management's RDY Position: Q2 2026 in Review

Drive Wealth Management reduced its Dr. Reddy's Laboratories (RDY) stake by 21% in Q2 2026, selling an estimated $45.8K and leaving 12,416 shares worth $180K. The position accounts for 0.03% of the portfolio, ranked #434.

Drive Wealth Management first reported a position in RDY in Q2 2024 and has held it in 9 quarters since. The position peaked at $220K in Q4 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Drive Wealth Management held 12,416 shares of Dr. Reddy's Laboratories worth $180K as of Q2 2026.
  • Drive Wealth Management sold 3,396 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $45.8K.
  • Dr. Reddy's Laboratories made up 0.03% of Drive Wealth Management's portfolio in Q2 2026, its #434 holding.
  • Drive Wealth Management first reported a position in Dr. Reddy's Laboratories in Q2 2024 and has held it in 9 quarters since.
  • Drive Wealth Management's Dr. Reddy's Laboratories position peaked at $220K in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Drive Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.